SCHEMBL19663966

SCHEMBL19663966

Cc1cccc(-c2n[nH]cc2C(=O)O)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AKR1C2 P52895 1/20 0.47
▸ AKR1C1 Q04828 1/20 0.47
▸ PIN1 Q13526 1/20 0.47
▸ DHODH Q02127 2/20 0.46
▸ KMO O15229 2/20 0.44
▸ JAK2 O60674 1/20 0.44
▸ JAK3 P52333 1/20 0.44
▸ NOTUM Q6P988 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ CSNK1D P48730 1/20 0.43
▸ CSNK1E P49674 1/20 0.43
▸ MAPK14 Q16539 1/20 0.43
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ MCL1 Q07820 1/20 0.41
▸ GRK6 P43250 1/20 0.41
▸ NPC1 O15118 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ TSHR P16473 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27717172 0.84 ACMSD (0.50) DHODHKMOMCL1KDM4E
SCHEMBL415485 0.82 KDM4E (0.55) MAPTPOLBMCL1SMN1; SMN2KDM4E
SCHEMBL3519078 0.82 MCL1 (0.51) MAPTMEN1KMT2APOLBMCL1
SCHEMBL28214966 0.82 DCLRE1B (0.47) PIN1DHODHKMOJAK2JAK3
SCHEMBL27579261 0.81 TPMT (0.43) DHODHMEN1KMT2APOLBNPC1
SCHEMBL16974002 0.81 SMN1; SMN2 (0.46) AKR1C2AKR1C1DHODHMAPTMEN1
Ethylene SCHEMBL27448159 0.79 KDM4E (0.51) MAPTPOLBMCL1SMN1; SMN2KDM4E
SCHEMBL25347360 0.77 TDP1 (0.59) MAPTMEN1KMT2AGRK6NPC1
SCHEMBL6850959 0.77 IDO1 (0.46) JAK2JAK3NOTUMMAPK14NPC1
SCHEMBL28192750 0.75 AKR1C3 (0.52) AKR1C2MAPTMEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3252050-A1 PHTHALAZINONES AND ISOQUINOLINONES AS ROCK INHIBITORS Bristol-Myers Squibb Company (US) 2017-12-06 — — EP disclosed
Send feedback